Using an ex vivo model recreating the scenario of an ascending infection, we demonstrated that only high concentrations of PRL, corresponding to those in AF, selectively reduce LPS-induced TNF-α and IL-1β release in the choriodecidual region but have no effect on IL-6 and IL-10 (48). The gene discussed is PRL; the disease is atrial fibrillation.